These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14673736)

  • 1. Prevention of black pigment gallstone formation after cardiac surgery by ursodeoxycholic acid.
    Abei M; Tanaka N
    J Gastroenterol; 2003; 38(11):1113-5. PubMed ID: 14673736
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of gallstones by ursodeoxycholic acid after cardiac surgery.
    Ai T; Azemoto R; Saisho H
    J Gastroenterol; 2003; 38(11):1071-6. PubMed ID: 14673725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
    Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
    Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
    Boerlage TCC; Haal S; Maurits de Brauw L; Acherman YIZ; Bruin S; van de Laar AWJM; Moes DE; van Wagensveld BA; de Vries CEE; van Veen R; Schouten R; Dijkgraaf MG; Fockens P; Gerdes VEA; Voermans RP
    BMC Gastroenterol; 2017 Dec; 17(1):164. PubMed ID: 29262795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of gallstones and gallbladder disease in patients undergoing gastric bypass.
    Quesada BM; Kohan G; Roff HE; Canullán CM; Chiappetta Porras LT
    World J Gastroenterol; 2010 May; 16(17):2075-9. PubMed ID: 20440847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ursodeoxycholic acid/dapsone interaction].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2003 Mar; 130(3):391. PubMed ID: 12746684
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease.
    Tsai S; Strouse PJ; Drongowski RA; Islam S; Teitelbaum DH
    J Pediatr Surg; 2005 Jan; 40(1):263-7. PubMed ID: 15868595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients developed symptomatic gallstones between 3 and 21 months after Roux-en-Y gastric bypass (RYGB), neither prophylactic cholecystectomy nor treatment with ursodeoxycholic acid is necessary after open RYGB.
    Sarr MG
    Surg Obes Relat Dis; 2006; 2(2):233; author reply 233. PubMed ID: 16925352
    [No Abstract]   [Full Text] [Related]  

  • 9. Gallstone disease: Primary and secondary prevention.
    Venneman NG; van Erpecum KJ
    Best Pract Res Clin Gastroenterol; 2006; 20(6):1063-73. PubMed ID: 17127188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ursodeoxycholic acid on inflammatory infiltrate in gallbladder muscle of cholesterol gallstone patients.
    Carotti S; Guarino MP; Cicala M; Perrone G; Alloni R; Segreto F; Rabitti C; Morini S
    Neurogastroenterol Motil; 2010 Aug; 22(8):866-73, e232. PubMed ID: 20426797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased number of activated macrophages in gallbladder muscle layer of cholesterol gallstone patients following ursodeoxycholic acid.
    Guarino MP; Carotti S; Morini S; Perrone G; Behar J; Altomare A; Alloni R; Caviglia R; Emerenziani S; Rabitti C; Cicala M
    Gut; 2008 Dec; 57(12):1740-1. PubMed ID: 19022933
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of biliary complications in bariatric surgery.
    Desbeaux A; Hec F; Andrieux S; Fayard A; Bresson R; Pruvot MH; Mulliez E
    J Visc Surg; 2010 Aug; 147(4):e217-20. PubMed ID: 20920904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gallstones following considerable weight loss and recommendations for their prevention].
    Mijnhout GS; Smulders YM; Craanen ME
    Ned Tijdschr Geneeskd; 2004 Jan; 148(4):174-7. PubMed ID: 14974308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin treatment prevents gallstone formation but mimics porcelain gallbladder in C57Bl/6 mice.
    Dorvash MR; Khoshnood MJ; Saber H; Dehghanian A; Mosaddeghi P; Firouzabadi N
    Eur J Pharmacol; 2018 Aug; 833():165-172. PubMed ID: 29883669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of ursodeoxycholic acid alone and ursodeoxycholic acid plus low-dose acetylsalicylic acid on radiolucent gallstones.
    Tuncer I; Harman M; Mercan R; Oztürk M; Arslan I; Meral C; Türkdoğan MK
    Turk J Gastroenterol; 2003 Jun; 14(2):91-6. PubMed ID: 14614633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial.
    Miller K; Hell E; Lang B; Lengauer E
    Ann Surg; 2003 Nov; 238(5):697-702. PubMed ID: 14578732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallstone disease: Microlithiasis and sludge.
    Jüngst C; Kullak-Ublick GA; Jüngst D
    Best Pract Res Clin Gastroenterol; 2006; 20(6):1053-62. PubMed ID: 17127187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary symptoms, gallbladder motility, and cholecystectomy.
    Colecchia A; Festi D
    Hepatology; 2007 Jan; 45(1):259-60. PubMed ID: 17187423
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological treatment of cholestasis.
    Alvaro D
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():47-51. PubMed ID: 8899693
    [No Abstract]   [Full Text] [Related]  

  • 20. Gallstone disease in children.
    Svensson J; Makin E
    Semin Pediatr Surg; 2012 Aug; 21(3):255-65. PubMed ID: 22800978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.